Benitec Biopharma Inc. Share-based Payment Arrangement, Expense in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Benitec Biopharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to Q3 2025.
  • Benitec Biopharma Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $5.18M, a 1091% increase year-over-year.
  • Benitec Biopharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $22.2M, a 1789% increase year-over-year.
  • Benitec Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2025 was $17.4M, a 2000% increase from 2024.
  • Benitec Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2024 was $830K, a 83.6% increase from 2023.
  • Benitec Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $452K, a 48% decline from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Benitec Biopharma Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $22.2M $5.18M +$4.75M +1091% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $17.4M $13.5M +$13M +2863% Apr 1, 2025 Jun 30, 2025 10-K 2025-09-22
Q1 2025 $4.43M $2.6M +$2.41M +1253% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $2.02M $943K +$850K +914% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q3 2024 $1.17M $435K +$344K +378% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $830K $454K +$327K +257% Apr 1, 2024 Jun 30, 2024 10-K 2025-09-22
Q1 2024 $503K $192K +$121K +170% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $382K $93K +$141K Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-14
Q3 2023 $241K $91K -$211K -69.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $452K $127K -$41K -24.4% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-26
Q1 2023 $493K $71K -$121K -63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $614K -$48K -$287K -120% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $901K $302K +$31K +11.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $870K $168K -$111K -39.8% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-21
Q1 2022 $981K $192K -$43K -18.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.02M $239K +$157K +191% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $867K $271K +$233K +613% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $634K $279K +$222K +389% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-02
Q1 2021 $412K $235K +$147K +167% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $265K $82K +$45K +122% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $220K $38K -$17K -30.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $237K $57K Apr 1, 2020 Jun 30, 2020 10-K 2021-09-20
Q1 2020 $88K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $37K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $55K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13

Benitec Biopharma Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $17.4M +$16.6M +2000% Jul 1, 2024 Jun 30, 2025 10-K 2025-09-22
2024 $830K +$378K +83.6% Jul 1, 2023 Jun 30, 2024 10-K 2025-09-22
2023 $452K -$418K -48% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2022 $870K +$236K +37.2% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-21
2021 $634K +$397K +168% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-02
2020 $237K -$435K -64.7% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-20
2019 $672K Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.